Systemic absorption and safety of topical terbinafine hydrochloride 10% solution (MOB015B): a phase 1 maximal usage trial in patients with moderate-to-severe onychomycosis
Systemic absorption and safety of topical terbinafine hydrochloride 10% solution (MOB015B): a phase 1 maximal usage trial in patients with moderate-to-severe onychomycosis
Janet DuBois, Aditya Kumar Gupta, Amir Tavakkol
Citations
3 citations
Journal
Antimicrobial Agents and Chemotherapy
Topics
Nail Diseases and Treatments
Field-Weighted Citation Impact (FWCI)
1.16
article
Systemic absorption and safety of topical terbinafine hydrochloride 10% solution (MOB015B): a phase 1 maximal usage trial in patients with moderate-to-severe onychomycosis
Janet DuBois, Aditya Kumar Gupta, Amir Tavakkol
article en
3 citations
Abstract
No abstract available for this paper.
Publication Tag
Antimicrobial Agents and ChemotherapyVol. 68(10)
Institutions
University of Toronto (CA), Moberg Pharma (Sweden) (SE), Mediprobe Research (Canada) (CA), DermResearch (United States) (US)